# Labelling and packaging of medicinal products for human use following agreement of the Windsor Framework

Source: https://www.keypedia.com/records/uk_mhra_guidance/uk-mhra/7bb3b961-36bc-46aa-801c-577e941eeb0a
Type: Guidance
Published: July 27, 2023
Updated: March 11, 2025

> Information on the implementation of labelling and packaging requirements for medicinal products for human use under the Windsor Framework.

---

## Content

This guidance is designed to provide information on the implementation of labelling and packaging requirements for medicinal products for human use under the Windsor Framework. The Windsor Framework sets out the long-term arrangements for the supply of medicines into Northern Ireland. It will ensure that medicines can be approved and licensed on a UK-wide basis by the Medicines and Healthcare products Regulatory Agency (MHRA) , with medicines using the same packaging and labelling across the UK, and provides for the disapplication of European Union (EU) Falsified Medicines Directive (FMD) requirements for medicines marketed and supplied in Northern Ireland.

## Attachments

- [Labelling and packaging of medicinal products for human use following agreement of the Windsor Framework](/government/publications/labelling-and-packaging-of-medicinal-products-for-human-use-following-agreement-of-the-windsor-framework/labelling-and-packaging-of-medicinal-products-for-human-use-following-agreement-of-the-windsor-framework)